BRO Quote, Financials, Valuation and Earnings

CorVel has a net margin of 19.73% compared to Brown & Brown's net margin of 10.43%. Brown & Brown's return on equity of 18.1% beat CorVel's return on equity of 32.6%.

Brown & Brown has a consensus price target of $115.28, signalling upside risk potential of 12.43%. On the other hand CorVel has an analysts' consensus of -- which suggests that it could fall by --. Given that Brown & Brown has higher upside potential than CorVel, analysts believe Brown & Brown is more attractive than CorVel.

Brown & Brown has a beta of 0.854, which suggesting that the stock is 14.568% less volatile than S&P 500. In comparison CorVel has a beta of 1.155, suggesting its more volatile than the S&P 500 by 15.453%.

Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.53%. CorVel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown pays 15.51% of its earnings as a dividend. CorVel pays out -- of its earnings as a dividend. Brown & Brown's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Brown & Brown quarterly revenues are $1.2B, which are larger than CorVel quarterly revenues of $224.4M. Brown & Brown's net income of $234M is higher than CorVel's net income of $23.4M. Notably, Brown & Brown's price-to-earnings ratio is 27.94x while CorVel's PE ratio is 69.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.37x versus 6.73x for CorVel. Usually stocks with elevated PS ratios are considered overvalued.

eHealth has a net margin of 19.73% compared to Brown & Brown's net margin of -72.72%. Brown & Brown's return on equity of 18.1% beat eHealth's return on equity of -5.64%.

Brown & Brown has a consensus price target of $115.28, signalling upside risk potential of 12.43%. On the other hand eHealth has an analysts' consensus of $7.00 which suggests that it could fall by -25.58%. Given that Brown & Brown has higher upside potential than eHealth, analysts believe Brown & Brown is more attractive than eHealth.

Brown & Brown has a beta of 0.854, which suggesting that the stock is 14.568% less volatile than S&P 500. In comparison eHealth has a beta of 0.311, suggesting its less volatile than the S&P 500 by 68.95%.

Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.53%. eHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown pays 15.51% of its earnings as a dividend. eHealth pays out -12.52% of its earnings as a dividend. Brown & Brown's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Brown & Brown quarterly revenues are $1.2B, which are larger than eHealth quarterly revenues of $58.4M. Brown & Brown's net income of $234M is higher than eHealth's net income of -$42.5M. Notably, Brown & Brown's price-to-earnings ratio is 27.94x while eHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.37x versus 0.62x for eHealth. Usually stocks with elevated PS ratios are considered overvalued.

Kingstone Companies has a net margin of 19.73% compared to Brown & Brown's net margin of 17.12%. Brown & Brown's return on equity of 18.1% beat Kingstone Companies's return on equity of 40.22%.

Brown & Brown has a consensus price target of $115.28, signalling upside risk potential of 12.43%. On the other hand Kingstone Companies has an analysts' consensus of -- which suggests that it could grow by 15.8%. Given that Kingstone Companies has higher upside potential than Brown & Brown, analysts believe Kingstone Companies is more attractive than Brown & Brown.

Brown & Brown has a beta of 0.854, which suggesting that the stock is 14.568% less volatile than S&P 500. In comparison Kingstone Companies has a beta of 0.738, suggesting its less volatile than the S&P 500 by 26.211%.

Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.53%. Kingstone Companies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown pays 15.51% of its earnings as a dividend. Kingstone Companies pays out -- of its earnings as a dividend. Brown & Brown's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Brown & Brown quarterly revenues are $1.2B, which are larger than Kingstone Companies quarterly revenues of $40.8M. Brown & Brown's net income of $234M is higher than Kingstone Companies's net income of $7M. Notably, Brown & Brown's price-to-earnings ratio is 27.94x while Kingstone Companies's PE ratio is 11.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.37x versus 1.16x for Kingstone Companies. Usually stocks with elevated PS ratios are considered overvalued.

Marsh & McLennan Companies has a net margin of 19.73% compared to Brown & Brown's net margin of 13.11%. Brown & Brown's return on equity of 18.1% beat Marsh & McLennan Companies's return on equity of 31.46%.

Brown & Brown has a consensus price target of $115.28, signalling upside risk potential of 12.43%. On the other hand Marsh & McLennan Companies has an analysts' consensus of $231.78 which suggests that it could grow by 9.67%. Given that Brown & Brown has higher upside potential than Marsh & McLennan Companies, analysts believe Brown & Brown is more attractive than Marsh & McLennan Companies.

Brown & Brown has a beta of 0.854, which suggesting that the stock is 14.568% less volatile than S&P 500. In comparison Marsh & McLennan Companies has a beta of 0.959, suggesting its less volatile than the S&P 500 by 4.147%.

Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.53%. Marsh & McLennan Companies offers a yield of 1.44% to investors and pays a quarterly dividend of $0.82 per share. Brown & Brown pays 15.51% of its earnings as a dividend. Marsh & McLennan Companies pays out 34.56% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Brown & Brown quarterly revenues are $1.2B, which are smaller than Marsh & McLennan Companies quarterly revenues of $5.7B. Brown & Brown's net income of $234M is lower than Marsh & McLennan Companies's net income of $747M. Notably, Brown & Brown's price-to-earnings ratio is 27.94x while Marsh & McLennan Companies's PE ratio is 26.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.37x versus 4.39x for Marsh & McLennan Companies. Usually stocks with elevated PS ratios are considered overvalued.